Two of the projects are SwafS-projects – Science with and for Society – granted as part of EU’s Horizon 2020 program. The third project is through EDCTPs Ethics and Regulatory Capacities.
"Getting one EU project is good. Getting three, that is fantastic to a small centre like us," says Reidar Pedersen, head of Centre for Medical Ethics (CME).
Project managers are Søren Holm, Jan Helge Solbakk and Rosemarie de la Cruz Bernabe.
ROSiE
The aim of the project Responsible Open Science in Europe (ROSiE) is to analyse ethical challenges in Open Science (OS) and Citizen Science (CS), and further develop practical
tools to ensure Ethics and research integrity (ERI) as a structural component.
Eleven European research institutions are involved in the project, coordinated by the University of Oslo through project leader Professor Søren Holm. Holm is working in collaboration with Researcher Rosemarie de la Cruz Bernabe, Professor Bjørn Hofmann, PhD-student Heidi Beate Bentzen, Professor Jan Helge Solbakk, Professor Anne Kari Tolo Heggestad, and Professor Emeritus Arild Jansen.
The project receives 2.5 million Euro in EU funding.
HYBRIDA
The HYBRIDA project intend to map out different types of organoids. Further, it shall develop
measuring tools to evaluate the effect of research on and with organoids, as well as suggest
ethical guidelines for this form of research. Organoids are mini organs developed from stem cells.
Eight European research institutions are involves in the project, coordinated by the University of Oslo through project leader Professor Jan Helge Solbakk. Solbakk is working in collaboration with Professor Stefan Krauss, Professor Bjørn Hofmann, Researcher Henrik Vogt and PhD-student Heidi Beate Bentzen.
The project receives 3 million Euro in EU funding.
Access Africa 1
This project is a collaboration between researchers in Norway, Ethiopia and Uganda, coordinated by the University of Oslo through project leader Rosemarie de la Cruz Bernabe.
Access Africa aims to contribute to the capacity building of national ethics committees and relevant drug regulatory agencies in Sub-Saharan Africa.
The project receives 500 000 Euro in EU funding.